Find Cysteamine Bitartrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

EU WC

0

KDMF

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Australia

0

South Africa

0

Listed Dossiers

FDF DossiersDRUG PRODUCT COMPOSITIONS

163RELATED EXCIPIENT COMPANIES

266EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 27761-19-9, Cysteamine (bitartrate), Mercamine bitartrate, Chebi:50386, Rp-103, Schembl49513
Molecular Formula
C6H13NO6S
Molecular Weight
227.24  g/mol
InChI Key
NSKJTUFFDRENDM-UHFFFAOYSA-N

Cysteamine Bitartrate
A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.
1 2D Structure

Cysteamine Bitartrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-aminoethanethiol;2,3-dihydroxybutanedioic acid
2.1.2 InChI
InChI=1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2
2.1.3 InChI Key
NSKJTUFFDRENDM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C(CS)N.C(C(C(=O)O)O)(C(=O)O)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 2 Aminoethanethiol

2. 2-aminoethanethiol

3. 35s-labeled Cysteamine

4. Becaptan

5. Beta Mercaptoethylamine

6. Beta-mercaptoethylamine

7. Bitartrate, Cysteamine

8. Cystagon

9. Cysteamine

10. Cysteamine Dihydrochloride

11. Cysteamine Hydrobromide

12. Cysteamine Hydrochloride

13. Cysteamine Maleate (1:1)

14. Cysteamine Tartrate

15. Cysteamine Tartrate (1:1)

16. Cysteamine Tosylate

17. Cysteamine, 35s Labeled

18. Cysteamine, 35s-labeled

19. Cysteinamine

20. Dihydrochloride, Cysteamine

21. Hydrobromide, Cysteamine

22. Hydrochloride, Cysteamine

23. Mercamine

24. Mercaptamine

25. Mercaptoethylamine

26. Tartrate, Cysteamine

27. Tosylate, Cysteamine

2.2.2 Depositor-Supplied Synonyms

1. 27761-19-9

2. Cysteamine (bitartrate)

3. Mercamine Bitartrate

4. Chebi:50386

5. Rp-103

6. Schembl49513

7. Chembl2062263

8. Bcp15048

9. Akos024332936

10. 2-aminoethanethiol 2,3-dihydroxysuccinate

11. Db-114321

12. Ft-0696891

13. 2-aminoethanethiol;2,3-dihydroxybutanedioic Acid

14. A900934

15. Q27122045

2.2.3 Other Synonyms

1. Cysteamine (usan)

2. Mecramine

2.3 Create Date
2007-12-05
3 Chemical and Physical Properties
Molecular Weight 227.24 g/mol
Molecular Formula C6H13NO6S
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass227.04635831 g/mol
Monoisotopic Mass227.04635831 g/mol
Topological Polar Surface Area142 Ų
Heavy Atom Count14
Formal Charge0
Complexity144
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Cystine Depleting Agents

Compounds and drugs that react with CYSTINE and convert it into a compound that can be more easily metabolized or intracellularly transported. Drugs in this class have been used to treat CYSTINOSIS. (See all compounds classified as Cystine Depleting Agents.)


4.2 FDA Pharmacological Classification
4.2.1 Pharmacological Classes
Cystine Disulfide Reduction [MoA]; Cystine Depleting Agent [EPC]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - EQ 2...DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - EQ 25MG BASE

USFDA APPLICATION NUMBER - 203389

read-more

DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - EQ 7...DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - EQ 75MG BASE

USFDA APPLICATION NUMBER - 203389

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Direct Compression

read-more
read-more

Lubricants & Glidants

read-more
read-more

Granulation

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Empty Capsules

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Topical

read-more
read-more

Vegetarian Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coloring Agents

read-more
read-more

Parenteral

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 27761-19-9 / Cysteamine Bitartrate API manufacturers, exporters & distributors?

Cysteamine Bitartrate manufacturers, exporters & distributors 1

61

PharmaCompass offers a list of Cysteamine Bitartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cysteamine Bitartrate manufacturer or Cysteamine Bitartrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cysteamine Bitartrate manufacturer or Cysteamine Bitartrate supplier.

API | Excipient name

Cysteamine Bitartrate

Synonyms

27761-19-9, Cysteamine (bitartrate), Mercamine bitartrate, Chebi:50386, Rp-103, Schembl49513

Cas Number

27761-19-9

About Cysteamine Bitartrate

A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.

Cysteamine Manufacturers

A Cysteamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cysteamine, including repackagers and relabelers. The FDA regulates Cysteamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cysteamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cysteamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Cysteamine Suppliers

A Cysteamine supplier is an individual or a company that provides Cysteamine active pharmaceutical ingredient (API) or Cysteamine finished formulations upon request. The Cysteamine suppliers may include Cysteamine API manufacturers, exporters, distributors and traders.

click here to find a list of Cysteamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Cysteamine USDMF

A Cysteamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cysteamine active pharmaceutical ingredient (API) in detail. Different forms of Cysteamine DMFs exist exist since differing nations have different regulations, such as Cysteamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Cysteamine DMF submitted to regulatory agencies in the US is known as a USDMF. Cysteamine USDMF includes data on Cysteamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cysteamine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Cysteamine suppliers with USDMF on PharmaCompass.

Cysteamine JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Cysteamine Drug Master File in Japan (Cysteamine JDMF) empowers Cysteamine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Cysteamine JDMF during the approval evaluation for pharmaceutical products. At the time of Cysteamine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Cysteamine suppliers with JDMF on PharmaCompass.

Cysteamine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cysteamine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Cysteamine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Cysteamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Cysteamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cysteamine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Cysteamine suppliers with NDC on PharmaCompass.

Cysteamine GMP

Cysteamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Cysteamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cysteamine GMP manufacturer or Cysteamine GMP API supplier for your needs.

Cysteamine CoA

A Cysteamine CoA (Certificate of Analysis) is a formal document that attests to Cysteamine's compliance with Cysteamine specifications and serves as a tool for batch-level quality control.

Cysteamine CoA mostly includes findings from lab analyses of a specific batch. For each Cysteamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Cysteamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cysteamine EP), Cysteamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cysteamine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty